Literature DB >> 19561107

Pathogen-induced interleukin-1beta processing and secretion is regulated by a biphasic redox response.

Sara Tassi1, Sonia Carta, Roberta Vené, Laura Delfino, Maria Rosa Ciriolo, Anna Rubartelli.   

Abstract

In this study, we show that IL-1beta processing and secretion induced by pathogen-associated molecular pattern (PAMP) molecules in human monocytes is regulated by a biphasic redox event including a prompt oxidative stress and a delayed antioxidant response. Namely, PAMPs induce an early generation of reactive oxygen species (ROS) followed by increase of intracellular thioredoxin and release of reduced cysteine: this antioxidant phase is paralleled by secretion of mature IL-1beta. ROS production and antioxidant response are both required, because either inhibitors of NADPH oxidase and of thioredoxin reductase impair IL-1beta secretion. These inhibitors also hinder cysteine release and consequently prevent reduction of the extracellular medium: addition of exogenous reducing agents restores IL-1beta secretion. Not only silencing of thioredoxin, but also of the ROS scavenger superoxide dismutase 1 results in inhibition of IL-1beta secretion. Thus, PAMP-induced ROS trigger an antioxidant response involving intracellular redox enzymes and release of cysteine, ultimately required for IL-1beta processing and secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561107     DOI: 10.4049/jimmunol.0900578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 2.  NLRP3 has a sweet tooth.

Authors:  Beckley K Davis; Jenny Pan-Yun Ting
Journal:  Nat Immunol       Date:  2010-02       Impact factor: 25.606

3.  Chemo-metabolic regulation of immune responses by Tregs.

Authors:  Anna Rubartelli; Roberto Sitia
Journal:  Nat Chem Biol       Date:  2009-10       Impact factor: 15.040

Review 4.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

5.  Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion.

Authors:  Sara Tassi; Sonia Carta; Laura Delfino; Roberta Caorsi; Alberto Martini; Marco Gattorno; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

Review 6.  Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?

Authors:  Justine M Abais; Min Xia; Yang Zhang; Krishna M Boini; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-01-19       Impact factor: 8.401

7.  A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation.

Authors:  Chunxia Lu; P Anil Kumar; Yong Fan; Mark A Sperling; Ram K Menon
Journal:  Endocrinology       Date:  2010-02-25       Impact factor: 4.736

8.  Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms.

Authors:  Jon R Ward; Peter W West; Mark P Ariaans; Lisa C Parker; Sheila E Francis; David C Crossman; Ian Sabroe; Heather L Wilson
Journal:  J Biol Chem       Date:  2010-05-21       Impact factor: 5.157

Review 9.  Redox control of inflammation in macrophages.

Authors:  Bernhard Brüne; Nathalie Dehne; Nina Grossmann; Michaela Jung; Dmitry Namgaladze; Tobias Schmid; Andreas von Knethen; Andreas Weigert
Journal:  Antioxid Redox Signal       Date:  2013-03-06       Impact factor: 8.401

10.  The IRAK-ERK-p67phox-Nox-2 axis mediates TLR4, 2-induced ROS production for IL-1β transcription and processing in monocytes.

Authors:  Ankita Singh; Vishal Singh; Rajiv L Tiwari; Tulika Chandra; Ashutosh Kumar; Madhu Dikshit; Manoj K Barthwal
Journal:  Cell Mol Immunol       Date:  2015-08-31       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.